Regulating TRAIL Receptor-Induced Cell Death at the Membrane: A Deadly Discussion

The use of TRAIL/APO2L and monoclonal antibodies targeting TRAIL receptors for cancer therapy holds great promise, due to their ability to restore cancer cell sensitivity to apoptosis in association with conventional chemotherapeutic drugs in a large variety of tumors. TRAIL-induced cell death is ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirley, Sarah, Morizot, Alexandre, Micheau, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2011
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204462/
https://www.ncbi.nlm.nih.gov/pubmed/21756247
http://dx.doi.org/10.2174/157489211796957757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204462/
https://www.ncbi.nlm.nih.gov/pubmed/21756247
http://dx.doi.org/10.2174/157489211796957757

Ejemplares similares